FDA Unwraps ‘Plausible Mechanism Pathway’ for Personalized Therapies

The plausible mechanism pathway “could accelerate gene therapy/editing development,” analysts at William Blair said Thursday, while adding that additional clarity is needed.

Scroll to Top